European Leukemia Trial Registry
Trial: AML -Intergroup

More Details
Scientific Title German AML-Intergroup study: therapy optimization and prognostic research in AML and MDS. Joint project with general upfront randomization between the individual study-therapy and a joint standard arm
Short Title AML -Intergroup
Trialgroup AML-Intergroup
Type of Trial randomized
Disease Acute myeloid leukemia(AML) Projekte
Myelodysplastic Syndrome(MDS) All subtypes
Acute myeloid leukemia(AML) AML all subtypes without FAB M3
Age <= 60 years
Status Closed
Start of Recruitment 29.06.2001
Leader Büchner, Prof. Dr. med., Thomas
Contactperson

General Contact Person
Büchner, Prof. Dr. med., Thomas
Tel: +49 (0)251 834 7597
Fax: +49 (0)251 834 9667
Email: buechnr@uni-muenster.de

General Contact Person
Döhner, Prof. Dr. med., Hartmut
Tel: +49 (0)731 50045501
Fax: +49 (0)731 50045905
Email: hartmut.doehner@uniklinik-ulm.de

General Contact Person
Ehninger, Prof. Dr. med., Gerhard
Tel: +49 (0)351 458 4251
Fax: +49 (0)351 458 4367
Email: gerhard.ehninger@uniklinikum-dresden.de

General Contact Person
Heil, Prof. Dr. med., Gerhard
Tel: +49 (0)2351 46 3540/1
Fax: +49 (0)2351 46 3539
Email: innere5@kkh-luedenscheid.de

General Contact Person
Niederwieser, Prof. Dr. med. Dr. h.c., Dietger
Tel: +49 (0)341 971 3050
Fax: +49 (0)341 971 3059
Email: dietger@medizin.uni-leipzig.de

Centre of Trial Universitätsklinikum Münster
Shortprotocol Shortprotocol
created 29.06.2006 Anja Hellenbrecht
changed 20.03.2015 Hanna Ebert
© ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org